Boston Scientific falls after cybersecurity incident causes disruption to operations

Up to the last close, the stock had fallen 47.7% year to date.

While the company is working diligently to restore affected functions and systems access, the timeline for a full restoration is not yet known, Boston Scientific said.

The company said the investigation of the cybersecurity incident is ongoing, and the full scope, nature and impacts, including operational and financial impacts, of the incident are not yet known.

Shares of medical device maker Boston Scientific BSX.N fell 3.5% to $48.13 premarket after the company said it identified a cybersecurity incident affecting some information technology systems that has resulted in a global disruption to its operations.

Boston Scientific said the incident is expected to cause further disruptions and limitations of access to certain information systems and business applications that support aspects of its operations, including the ability to process and ship customer orders.